Braveheart Bio
BRVE20.0204.87% ( +0.930 )
已收盤: 10月9日 16:00:00 (美東)全部股東
股東類型
- 創投/私募60.44%
- 公眾及其他15.31%
- 個人與內幕人士14.88%
- 上市公司9.09%
- 機構投資者0.27%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Forbion Capital Partners B.V. | 26.74% | 2,182.60 萬 | 23.40% | +2,157.43 萬 | |
OrbiMed Advisors LLC | 14.91% | 1,217.52 萬 | -- | +1,217.52 萬 | |
Andreessen Horowitz LLC | 12.53% | 1,023.24 萬 | -- | +1,023.24 萬 | |
Travis MurdochCEO, President & Director | 10.21% | 833.36 萬 | 14.79% | +645.00 萬 | |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 9.09% | 742.01 萬 | -- | +742.01 萬 | |
Frazier Life Sciences Management, LP | 6.26% | 510.74 萬 | -- | +510.74 萬 | |
Jason ColomaFormer Director | 1.35% | 110.05 萬 | 1.99% | +84.92 萬 | |
David MalekDirector | 1.24% | 101.33 萬 | 1.82% | +78.29 萬 | |
James RickeyChief Financial Officer | 0.86% | 70.36 萬 | 1.19% | +54.93 萬 | |
Christopher ViehbacherIndependent Chairman | 0.75% | 60.95 萬 | 1.30% | +45.51 萬 | |
Michele AndersonChief Development Officer | 0.41% | 33.22 萬 | 0.60% | +25.66 萬 | |
Charles Schwab Investment Management, Inc. | 0.16% | 12.97 萬 | -- | +12.97 萬 | |
David LubnerIndependent Director | 0.07% | 5.56 萬 | -- | +5.56 萬 | |
Vanguard Capital Management, LLC | 0.06% | 5.26 萬 | -- | +5.26 萬 | 31/08/2026 |
FMR LLC | 0.02% | 1.28 萬 | -- | +1.28 萬 | 30/09/2026 |
Vanguard Portfolio Management, LLC | <0.01% | 1,076.00 | -- | +1,076.00 | 31/08/2026 |